Biotech Stock Alert; Complete Genomics (NasdaqGM: GNOM) Gains over 30% in Morning Trades

New York, NY - May 25, 2012 - www.InvestorIdeas.com, a global investor research specializing in sector research including China stocks, issues an investor alert for Complete Genomics, Inc. (NasdaqGM: GNOM), continuing on yesterday’s gains, trading up at $3.03, up 0.70 (30.04%) 10:30AM EDT on over 9 Million shares . GNOM is the top percentage gainer on NASDAQ as of the time of this report.
The Company announced earlier this month that it had sequenced the genomes of 600 individuals from 20 Mexican-American families from San Antonio in what is thought to be the largest whole genome sequencing family study conducted to date and the first such study of its kind in a Latino population.
About Complete Genomics
Complete Genomics is the whole human genome sequencing company that has developed and commercialized an innovative DNA sequencing service. The Complete Genomics Analysis Platform (CGA(TM) Platform) combines Complete Genomics' proprietary human genome sequencing technology with advanced informatics and data management software. Additional information can be found at http://www.completegenomics.com

Research more biotech and pharma stocks with Investorideas.com global stock directory :
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; China stocks, renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Get Free investor news and stock alerts at Investorideas.com
Sign Up
Join Investor Ideas Get 13 of the best stock directories online;
Research China stocks, oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join:
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com